• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Clotrisone
    / Taro


    Active Ingredient *
    Betamethasone (dipropionate) 0.064% w/w.
    Clotrimazole 1% w/w

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Cream

    15 gr

    not in the basket chart 12213 3784

    Dosage

    Apply thin layer to affected area twice a day.


    Indications

    Topical treatment of the following dermal infections: Tinea pedis, tinea cruris and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosusm.


    Contra-Indications

    Patients with a history of sensitivity to any of its components or to other corticosteroids or imidazoles. Not recommended in patients under the age of 17 years and not recommended for diaper dermatitis.


    Special Precautions

    The efficacy for the treatment of infections caused by zoophilic dermatophytes (e.g. microsporum canis) has not been established. Should not be used in the treatment of: Facial rosea; acne vulgaris; perioral dermatitis; perianal and genital pruritus; napkin eruptions; bacterial or viral (i.e. herpes simplex) infections (concomitant therapy should be administered. If a favorable response does not occur promptly, treatment with this preparation should be discontinued until the infection has been controlled adequately); tubercular infections of the skin. Patients receiving a large dose of a potent topical steroid applied to a large surface area, should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH simulation tests. Patients should be advised to report any signs of local adverse reactions. Pregnancy and lactation: Studies have not shown that clotrimazole causes adverse effects on the fetus, but the preparation should be used only if the potential benefit justifies the potential risk to the fetus, and such use should not be extensive. Caution should be exercised when this preparation is used by nursing women. Should not be applied to the breasts prior to nursing. See prescribing information for full details. Long term continuous therapy should be avoided. When using this medicdbation in the groin area, patients should use the medicdbation for two weeks only.


    Side Effects

    Erythema, stinging, blistering, peeling, edema, pruritus, urticaria, general irritation of the skin. Allergic contact dermatitis, folliculitis, furunculosis, pustules, pyoderma or vesiculation, hyperesthesia, numbness in fingers, purpura, skin atrophy, secondary skin infection, telangiectasia, acneiform eruptions, dryness of skin, redness of skin. Hypothalamic-pituitary-adrenal (HPA) axis suppression. Manifestation of Cushing’s syndrome, hyperglycemia, glucosuria, protein catabolism, peptic ulcer activation, hypertension. Parasthesia, maculopapular rash.


    Manufacturer
    Taro Pharmaceutical Industries

    סרגל נגישות

    CLOSE